The Government of Senegal is reviewing and revising its new biosafety law which may include language for an expedited approval process for certain genetically engineered (GE) products. A draft regional biosafety law is also still pending approval by the Economic Community of West African States members. Because reliable information is limited, many West Africans are not well informed about the issues involved with biotechnology. Gaining future market acceptance will depend on efforts to inform and educate the public about the safety and benefits of biotechnology products. This is a regional report on West Africa that primarily covers Senegal, Burkina Faso, and Mali, but also provides brief overviews in certain sections for Niger, The Gambia, Guinea, Guinea-Bissau, and Mauritania.